Gastroenterology clinical trials recruiting in Illinois

61 recruiting gastroenterology trials match in Illinois. Showing 20.

• LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Des Plaines, Illinois

• Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) SymptomsRecruiting

  N/A · Gerd Care Medical Ltd · Afula

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisRecruiting

  Phase 2 · Sanofi · Glenview, Illinois

• Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruiting

  N/A · Fresenius Kabi · Chicago, Illinois

• A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier HomeostasisRecruiting

  N/A · Rush University Medical Center · Chicago, Illinois

• Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHRecruiting

  Phase 2 · Madrigal Pharmaceuticals, Inc. · Chicago, Illinois

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Chicago, Illinois

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Chicago, Illinois

• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruiting

  Phase 2 · Spyre Therapeutics, Inc. · Chicago, Illinois

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Sanofi · Chicago, Illinois

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Evanston, Illinois

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruiting

  Phase 2 / Phase 3 · Bristol-Myers Squibb · Loma Linda, California

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Hoffmann-La Roche · Glenview, Illinois

• Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesRecruiting

  Phase 2 · Northwestern University · Chicago, Illinois

• A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel SyndromeRecruiting

  N/A · PGP Health · Bolingbrook, Illinois

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Oak Lawn, Illinois

• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)Recruiting

  Phase 4 · Takeda · Chicago, Illinois

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Morton, Illinois

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruiting

  Phase 3 · Akero Therapeutics, Inc · Chicago, Illinois

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Janssen Research & Development, LLC · Dothan, Alabama

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.